Status:

UNKNOWN

Diuretic Versus Placebo in Pulmonary Embolism

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Pulmonary Embolism With Right Ventricle Enlargement

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Pulmonary Embolism (PE) is a frequent and severe disease with an annual incidence of about 75000 cases in France and a short-term mortality rate of about 10%. Death is usually related to an acute righ...

Eligibility Criteria

Inclusion

  • Patients aged 18 years and over with
  • Symptomatic acute pulmonary embolism with first clinical symptoms within 15 days, and objectively confirmed by CT scan
  • RV dysfunction (≥1 criterion) confirmed by elevated BNP value or echocardiography or spiral computed tomography of the chest:
  • Echocardiography
  • o Right/Left ventricular end diastolic diameter \> 1(apical or subcostal 4-chamber view)
  • Computed tomography
  • o Right/Left short-axis diameter ratio\>0.9 (transverse plane)
  • Positive Nt-proBNP (\>600) or BNP\>200 pg/mL
  • One abnormal following PESI criteria
  • Heart Rate\>110/min
  • Systolic blood pressure\<100mmHg
  • Arterial oxyhemoglobin level\<90% on room air or after 5 minutes of oxygen withdrawal.

Exclusion

  • Cardiogenic shock requiring thrombolysis
  • Previous significant left ventricular insufficiency (LVEF\<45%)
  • Systolic blood pressure\<90mmHg at admission
  • Age ≤ 18 years
  • Pregnancy
  • No health insurance
  • Patients deprived of liberty or under legal protection
  • Creatinin clearance \<30mL/min/m²
  • hypersensibility to furosemide or its excipients
  • functional renal insufficiency
  • Hepatic encephalopathy
  • Urinary tracks obstruction
  • Hypovolemia or dehydration.
  • Sever hypokalemia (K+ \< 3mmol/L)
  • Severe hyponatremia (Na+ \< 125mmol/L)
  • Ongoing hepatitis and hepatic insufficiency severe in patients with renal insufficiency or dialysis

Key Trial Info

Start Date :

April 13 2015

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2018

Estimated Enrollment :

270 Patients enrolled

Trial Details

Trial ID

NCT02268903

Start Date

April 13 2015

End Date

May 1 2018

Last Update

October 19 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Henri Mondor Hospital

Créteil, France, 94010